Optimization of beam orientation and virtual organ delineation for lung IMRT
详细信息 查看全文
- 作者：Kyung Hwan Chang (1)
Suk Lee (1)
Yuan Jie Cao (1)
Jang Bo Shim (1)
Ji Eun Lee (1)
Jung Ae Lee (1)
Dae Sik Yang (1)
Young Je Park (1)
Won Sup Yoon (1)
Chul Yong Kim (1)
Sam Ju Cho (2)
Sang Hoon Lee (3)
Woo Chul Kim (4)
Chul Kee Min (4)
Kwang Hwan Cho (4)
Hyun Do Huh (5) - 关键词：IMRT ; Virtual organ delineation (VOD) ; Optimization ; Lung cancer
- 刊名：Journal of the Korean Physical Society
- 出版年：2014
- 出版时间：April 2014
- 年：2014
- 卷：64
- 期：7
- 页码：1047-1054
- 全文大小：
- 参考文献：1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu and M. J. Thun, CA Cancer J. Clini. 59, 225 (2009). CrossRef
2. Y. Chen, K. J. Pandya, O. Hyrien, P. C. Keng, T. Smudzin, J. Anderson, R. Qazi, B. Smith, T. J. Watson, R. H. Feins and D. W. Johnstone, Int. J. Radiat. Oncol. Biol. Phys. 80, 1358 (2011). CrossRef
3. E. J. Koay, D. Lege, R. Mohan, R. Komaki, J. D. Cox and J. Y. Chang, Int. J. Radiat. Oncol. Biol. Phys. 84, 1093 (2012). CrossRef
4. C. A. Perez, L.W. Brady and E. C. Halperin, / Pere鈥檢 and Brady鈥檚 Principles and Practices of Radiation Oncology (Lippincott Williams & Wilkins, Philadelphia, 2008).
5. H. Ikushima, P. Balter, R. Komaki, S. Hunjun, M. K. Bucci, Z. Liao, M. F. McAleer, Z. H. Yu, Y. Zhang, J. Y. Chang and L. Dong, Int. J. Radiat. Oncol. Biol. Phys. 79, 473 (2011). CrossRef
6. J. S. Shin, E. Shin, Y. Han, S. G. Ju, J. S. Kim, S. H. Ahn, T. G. Kim, B. K. Jeong, H. C. Park, Y. C. Ahn and D. H. Choi, Radiat. Oncol. J. 29, 206 (2011). CrossRef
7. F. M. Kong / et al., Int. J. Radiat. Oncol. Biol. Phys. 65, 1075 (2006). CrossRef
8. H. H. Liu / et al., Int. J. Radiat. Oncol. Biol. Phys. 58, 1268 (2004). CrossRef
9. S. A. Oh, M. K. Kang and S. K. Kim, Prog. Med. Phys. 24, 145 (2013). CrossRef
10. M. P. Mac Manus, Z. Ding, A. Hogg, A. Herschtal, D. Binns, D. L. Ball and R. J. Hicks, Int. J. Radiat. Oncol. Biol. Phys. 80, 1365 (2011). CrossRef
11. R. B. Barriger, A. J. Fakiris, N. Hanna, M. Yu, P. Mantravadi and R. C. McGarry, Int. J. Radiat. Oncol. Biol. Phys. 78, 1381 (2010). CrossRef
12. M. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett and C. A. Perez, Int. J. Radiat. Oncol. Biol. Phys. 45, 323 (1999). CrossRef
13. A. Pugachev, J. G. Li, A. L. Boyer, S. L. Hancock, Q. T. Le, S. S. Donaldson and L. Xing, Int. J. Radiat. Oncol. Biol. Phys. 50, 551 (2001). CrossRef
14. A. Pugachev and L. Xing, Int. J. Radiat. Oncol. Biol. Phys. 51, 1361 (2001). CrossRef
15. S. Gaede and E. Wong, Med. Phys. 31, 376 (2004). CrossRef
16. D. Djajaputra, Q. Wu, Y. Wu and R. Mohan, Phys. Med. Biol. 48, 3191 (2003). CrossRef
17. S. Lee, J. Seong and Y. B. Kim, J. Korean Soc. Therap. Radio. Oncol. 19, 319 (2001).
18. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin and M. Wesson, Int. J. Radiat. Oncol. Biol. Phys. 21, 109 (1991). CrossRef
19. RTOG Protocol 0412. Phase III randomized trial of preoperative chemotherapy versus preoperative concurrent chemotherapy and thoracic radiotherapy followed by surgical resection and consolidation chemotherapy in favorable prognosis patients with stage III (N2) non-small cell lung cancer. 2005.
20. E. Weiss, J. V. Siebers and P. J. Keall, Radiother. Oncol. 82, 55 (2007). CrossRef - 作者单位：Kyung Hwan Chang (1)
Suk Lee (1)
Yuan Jie Cao (1)
Jang Bo Shim (1)
Ji Eun Lee (1)
Jung Ae Lee (1)
Dae Sik Yang (1)
Young Je Park (1)
Won Sup Yoon (1)
Chul Yong Kim (1)
Sam Ju Cho (2)
Sang Hoon Lee (3)
Woo Chul Kim (4)
Chul Kee Min (4)
Kwang Hwan Cho (4)
Hyun Do Huh (5)
1. Department of Radiation Oncology, College of Medicine, Korea University, Seoul, 130-701, Korea
2. Department of Radiology Science, Eulji University, Seongnam, 461-713, Korea
3. Department of Radiation Oncology, Cheil General Hospital & Women鈥檚 Healthcare Center, Kwandong University College of Medicine, Seoul, 100-380, Korea
4. Department of Radiation Oncology, Soonchunhyang University Hospital, Bucheon, 420-767, Korea
5. Department of Radiation Oncology, Inha University Hospital, Incheon, 400-711, Korea - ISSN：1976-8524
文摘
This study demonstrates the feasibility of the proposed intensity-modulated radiotherapy (IMRT) techniques for minimizing the dose to the lungs and organs at risk (OARs) for variations in the number of beams, the orientations of the beams, the virtual organ delineation (VOD) position, the VOD size and the dose constraints in order to optimize the treatment plan for lung cancer. We used 5, 7, 9 and 14 equiangularly-spaced beams and 7 and 9 non-equiangularly-spaced beams. We measured the volume of the lungs receiving at least 20 Gy and 25 Gy (V20 and V25) for variations in the orientations of the beams, the VOD position, and the size of the tumor and the contra-lateral lung. For the tumor and the contra-lateral lung, the V20 and the V25 values of 14 equiangularlyspaced ports were slightly lower than those of other equiangularly-spaced beam orientations. For non-equiangularly-spaced beam orientations, the lowest V20 and V25 values in the tumor and the contral-lateral lung were recorded in ports 7, and 9, respectively. For tumors of the lung, the average values of 7 non-equiangularly-spaced ports were lower than those for 14 equiangularly-spaced ports. The values of V20 and V25 for variations in the VOD size and the VOD position showed no significant differences for the lung tumor of patient 1 when the dose constraint of the VOD was 10, 25 and 30 Gy. For the lung tumor, the values of V20 and V25 for various VOD sizes and positions ranged from 15 to 37% in patient 2 and from 28 to 45% in patient 3. The values of V20 and V25 were within 7% for the contra-lateral lung of patient 1. For patient 2, the values of V20 and V25 ranged from 7 to 18%. For the contra-lateral lung of patient 3, the V20 and V25 values ranged from 12 to 25%. IMRT techniques with various VOD and beam orientations are important for determine in treatment plans.